Equities

Nuveen Insured New York Tax Free Advantage Municipal Fund

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NRK:NYQ

Nuveen Insured New York Tax Free Advantage Municipal Fund

Actions
FinancialsClosed End Investments
  • Price (USD)10.49
  • Today's Change-0.11 / -1.04%
  • Shares traded515.15k
  • 1 Year change-1.78%
  • Beta0.6716
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nuveen New York AMT-Free Quality Municipal Income Fund (Fund) is a closed-end management investment company. The Fund's investment objectives are to provide current income exempt from regular federal, New York State and New York City income taxes and from the federal alternative minimum tax (AMT) applicable to individuals. Its objective is to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The Fund invests at least 80% of its assets in municipal securities and other related investments the income from which is exempt. The Fund invests in various municipal securities, including municipal bonds and notes, other securities issued to finance and refinance public projects, and other related securities and derivative instruments. The investment advisor of the Fund is Nuveen Fund Advisors, LLC.

  • Revenue in USD (TTM)76.70m
  • Net income in USD-77.03m
  • Incorporated2002
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
GAMCO Global Gold Ntrl Rsrcs & Incm Trst21.68m131.13m881.73m--6.721.25--40.670.84020.84020.13865.010.0275--5.90--17.126.5417.246.6263.4563.33622.76235.11----0.0256135.80-4.8813.68-45.86-17.99---9.71
Ridgepost Capital Inc297.35m19.50m883.71m326.0048.742.5218.162.970.16560.16562.523.210.3308--8.04912,104.302.551.893.132.26----7.726.33--3.340.480582.340.302934.574.28-3.32172.48--
Pimco Corporate & Income Strategy Fund84.29m95.13m895.96m--8.641.06--10.631.451.451.2611.820.0973--5.50--10.985.7913.008.0989.6485.57112.8975.59----0.0637134.7225.336.7732.91----0.00
Barings BDC Inc279.21m101.92m897.34m0.008.850.7731--3.210.96870.96872.6511.090.1047--3.63--3.823.413.893.4646.3650.2836.5034.95--7.690.552115.94-2.4331.49-7.5865.63--9.86
AllianceBernstein Global Hgh Incm Fd Inc-100.00bn-100.00bn898.51m0.00------------------------------------------------------------
Calamos Convertible Opprtnts nd Incm Fnd-100.00bn-100.00bn909.35m--------------------------------------------------------------
John Hancock Tx dvntgd Dvdnd ncm Fnd-100.00bn-100.00bn909.89m0.00------------------------------------------------------------
Blackrock Enhancd Large Cap Core Fnd Inc8.40m117.56m913.70m--7.710.986--108.792.902.900.208122.650.0088--9.67--12.2910.1812.5810.348.2531.511,399.70829.38----0.0065.930.6546-6.95-18.10-5.18--4.36
Nuveen New York AMT-Fr Qty Mnpl Incm Fd76.70m-77.03m915.10m----1.02--11.93-0.8831-0.88310.879210.30----------------53.19---100.44----0.34570.4297--------------
BlackRock Health Sciences Term Trust29.84m-68.50m917.52m----0.9577--30.74-1.06-1.060.376615.330.0206--14.73---4.72---4.74--32.62---229.52----0.10050.00--135.12---66.00------
Kayne Anderson BDC Inc230.26m107.19m926.97m0.009.160.8469--4.031.511.513.2516.340.1055--30.73--4.91--5.05--51.44--46.55----9.890.5028--32.36--71.18------
Virtus Investment Partners Inc852.87m138.40m935.50m801.006.991.004.691.1019.9919.99123.07139.510.2059--7.761,064,750.003.284.113.654.66----15.9417.88----0.72637.07-5.967.1513.6811.6045.8825.56
Calamos Convertible and High Income Fund21.85m185.97m945.10m--5.151.00--43.262.292.290.27311.780.0159--2.22--13.574.8913.674.9249.0734.44851.23377.26----0.3344123.719.45-17.664.05-3.66--3.30
Oppenheimer Holdings Inc1.64bn148.40m950.16m2.98k6.82--11.480.5813.0213.02143.90------------------98.3098.129.036.46--3.44----14.356.45107.393.83--8.45
MidCap Financial Investment Corp320.88m63.17m962.69m0.0015.470.7364--3.000.67490.67493.4414.180.0985--10.11--1.94--1.99--47.82--19.69----1.880.6042--6.33---36.08------
Data as of Mar 03 2026. Currency figures normalised to Nuveen Insured New York Tax Free Advantage Municipal Fund's reporting currency: US Dollar USD

Institutional shareholders

12.47%Per cent of shares held by top holders
HolderShares% Held
Karpus Management, Inc.as of 31 Dec 20253.54m4.05%
Guggenheim Partners Investment Management LLCas of 31 Dec 20251.32m1.51%
RiverNorth Capital Management LLCas of 31 Dec 20251.27m1.46%
Parametric Portfolio Associates LLCas of 31 Dec 20251.27m1.45%
MacKay Shields LLCas of 31 Dec 2025641.11k0.74%
Wells Fargo Clearing Services LLCas of 31 Dec 2025638.76k0.73%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2025615.38k0.71%
CF Capital LLCas of 31 Dec 2025601.21k0.69%
Hennion & Walsh Asset Management, Inc.as of 31 Dec 2025529.10k0.61%
Fiera Capital, Inc.as of 31 Dec 2025460.80k0.53%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.